Grant is closed
Jul 2014 – Dec 2018
Human papilloma virus vaccinations for adolescent girls
Multiple countries – Africa
To support the Global Vaccine Alliance's programme to prevent cervical cancer, the leading cause of cancer-related deaths among women in Sub-Saharan Africa
$25,000,000 Grant Value
Gavi Matching Fund
The programme supports Gavi to purchase the human papillomavirus vaccine to offer adolescent girls protection against cervical cancer. The human papillomavirus (HPV) is the main cause of cervical cancer.
Cervical cancer claims the lives of 266,000 women each year, mainly in developing countries. UN Secretary General Ban Ki-moon highlighted this fact when he noted that "the world's poorest countries are home to more than 8 in 10 women with newly diagnosed cervical cancer, and 9 in 10 deaths from the disease."
In Africa, more than 93,000 women contract cervical cancer each year. Some 57,000 die from the disease. This leaves infants and children without a female caregiver and often the head of the household who provides for the family.
The programme supports eligible countries to experiment with a range of health delivery platforms to reach adolescent girls before scaling up access nationwide. It also helps countries to join up HPV vaccination efforts and other adolescent health interventions.
By 2020, Gavi is aiming for more than 30 million girls in over 40 countries to have been vaccinated against the human papillomavirus.
Using schools to administer the vaccine has proven successful, but efforts to reach out-of-school girls and align vaccination sessions with the school calendar will require significantly more resources.
It is also taking longer than expected for countries to take on board lessons learned from their demonstration programmes. The majority of countries are learning through HPV demonstration programmes.
To ensure a smooth transition from demonstration projects to national introduction, Gavi now offers a year of funding support to ensure girls do not miss out during the application and review process.